Cargando…
The metabolic bone disease associated with the Hyp mutation is independent of osteoblastic HIF1α expression
Fibroblast growth factor-23 (FGF23) controls key responses to systemic phosphate increases through its phosphaturic actions on the kidney. In addition to stimulation by phosphate, FGF23 positively responds to iron deficiency anemia and hypoxia in rodent models and in humans. The disorder X-linked hy...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365303/ https://www.ncbi.nlm.nih.gov/pubmed/28377980 http://dx.doi.org/10.1016/j.bonr.2017.01.003 |